{"id":60379,"date":"2020-02-25T11:22:10","date_gmt":"2020-02-25T09:22:10","guid":{"rendered":"http:\/\/realitatearutiera.ro\/?p=60379"},"modified":"2020-02-25T11:22:12","modified_gmt":"2020-02-25T09:22:12","slug":"oms-un-medicament-al-companiei-gilead-sciences-ar-putea-trata-simptomele-coronavirusului","status":"publish","type":"post","link":"https:\/\/realitatearutiera.ro\/?p=60379","title":{"rendered":"OMS: Un medicament al companiei Gilead Sciences ar putea trata simptomele coronavirusului"},"content":{"rendered":"\n<p> Ac\u0163iunile companiei americane Gilead Sciences au crescut, luni, cu 4% dup\u0103 ce un oficial de la Organiza\u0163ia Mondial\u0103 a S\u0103n\u0103t\u0103\u0163ii (OMS) a declarat c\u0103 un medicament creat de firma de biotehnologie ar putea ajuta la tratarea simptomelor coronavirusului, informeaz\u0103 CNN. <\/p>\n\n\n\n<p> Gilead Sciences (GILD) a fost una dintre cele dou\u0103 companii ale c\u0103ror ac\u0163iuni au crescut, luni, \u00een condi\u0163iile \u00een care Dow Jones Industrial Average a sc\u0103zut cu peste 1.000 de puncte, \u00een urma incertitudinilor generate de r\u0103sp\u00e2ndirea COVID-19 \u00een Italia, Coreea de Sud \u015fi Iran.<\/p>\n\n\n\n<p> \u00a0 \u201eExist\u0103 doar un singur medicament eficient \u00een acest moment, iar noi credem c\u0103 este Remdesivir\u201d, a declarat Bruce Aylward, director general adjunct la OMS, \u00een timpul unei conferin\u0163e de pres\u0103 sus\u0163inute la Beijing, arat\u0103 digi24.ro. \u00a0 Oficialii de la OMS au ad\u0103ugat c\u0103 studiile clinice cu Remdesivir asupra oamenilor sunt \u00een desf\u0103\u015furare \u015fi c\u0103 rezultatele ar putea fi disponibile \u00een doar c\u00e2teva s\u0103pt\u0103m\u00e2ni. <\/p>\n\n\n\n<p>\u00a0 Compania american\u0103 Gilead Sciences a confirmat c\u0103 deja colaboreaz\u0103 cu autorit\u0103\u0163ile medicale din China, \u00een cadrul a dou\u0103 studii clinice cu pacien\u0163i infeca\u0163i cu COVID-19, numele oficial al acestei tulpine de coronavirus. \u00a0 <\/p>\n\n\n\n<p>\u201eCele dou\u0103 studii &#8211; unul asupra pacien\u0163ilor cu o form\u0103 grav\u0103 a bolii, iar altul asupra celor cu o form\u0103 moderat\u0103 a infec\u0163iei &#8211; accept\u0103 momentan \u00eenscrierea participan\u0163ilor \u015fi anticip\u0103m apari\u0163ia primelor rezultate \u00een aprilie\u201d, a afirmat un purt\u0103tor de cuv\u00e2nt de la Gilead Sciences. \u00a0 <\/p>\n\n\n\n<p>Compania de biotehnologie a mai declarat la \u00eenceputul acestei luni c\u0103 lucreaz\u0103 \u00eendeaproape cu autorit\u0103\u0163ile din China pentru a afla dac\u0103 Remdesivir, un medicament experimental care a fost folosit pentru tratarea Ebola, ar putea combate simptomele coronavirusului.<\/p>\n\n\n\n<p>Sursa:adevarul<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ac\u0163iunile companiei americane Gilead Sciences au crescut, luni, cu 4% dup\u0103 ce un oficial de la Organiza\u0163ia Mondial\u0103 a S\u0103n\u0103t\u0103\u0163ii<\/p>\n","protected":false},"author":1,"featured_media":60380,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"spay_email":"","footnotes":"","jetpack_publicize_message":""},"categories":[6],"tags":[],"class_list":["post-60379","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-social"],"jetpack_featured_media_url":"https:\/\/i0.wp.com\/realitatearutiera.ro\/wp-content\/uploads\/2020\/02\/ERbtmt-XUAIovf5-324x160-1.jpg?fit=324%2C160&ssl=1","jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_shortlink":"https:\/\/wp.me\/p61naM-fHR","jetpack-related-posts":[],"_links":{"self":[{"href":"https:\/\/realitatearutiera.ro\/index.php?rest_route=\/wp\/v2\/posts\/60379","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/realitatearutiera.ro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/realitatearutiera.ro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/realitatearutiera.ro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/realitatearutiera.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=60379"}],"version-history":[{"count":1,"href":"https:\/\/realitatearutiera.ro\/index.php?rest_route=\/wp\/v2\/posts\/60379\/revisions"}],"predecessor-version":[{"id":60381,"href":"https:\/\/realitatearutiera.ro\/index.php?rest_route=\/wp\/v2\/posts\/60379\/revisions\/60381"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/realitatearutiera.ro\/index.php?rest_route=\/wp\/v2\/media\/60380"}],"wp:attachment":[{"href":"https:\/\/realitatearutiera.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=60379"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/realitatearutiera.ro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=60379"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/realitatearutiera.ro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=60379"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}